Cargando…

Tenascin-C and integrins in cancer

Tenascin-C (TNC) is highly expressed in cancer tissues. Its cellular sources are cancer and stromal cells, including fibroblasts/myofibroblasts, and also vascular cells. TNC expressed in cancer tissues dominantly contains large splice variants. Deposition of the stroma promotes the epithelial-mesenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Toshimichi, Akatsuka, Tatsuya, Imanaka-Yoshida, Kyoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422796/ https://www.ncbi.nlm.nih.gov/pubmed/25793576 http://dx.doi.org/10.1080/19336918.2015.1008332

Ejemplares similares

Tenascin-C in Heart Diseases—The Role of Inflammation
por: Imanaka-Yoshida, Kyoko
Publicado: (2021)

Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system
por: Imanaka-Yoshida, Kyoko, et al.
Publicado: (2014)

Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta
por: Imanaka-Yoshida, Kyoko, et al.
Publicado: (2018)

Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C
por: Yonebayashi, Saori, et al.
Publicado: (2021)

Tenascin-C in Osteoarthritis and Rheumatoid Arthritis
por: Hasegawa, Masahiro, et al.
Publicado: (2020)

Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion
por: Taki, Junichi, et al.
Publicado: (2015)

Tenascin‐C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
por: Machino‐Ohtsuka, Tomoko, et al.
Publicado: (2014)

Editorial: Tenascins – Key Players in Tissue Homeostasis and Defense
por: Yoshida, Kyoko Imanaka, et al.
Publicado: (2022)

Tenascin-C in Tissue Repair after Myocardial Infarction in Humans
por: Matsui, Kenta, et al.
Publicado: (2023)

Tenascin C protects aorta from acute dissection in mice
por: Kimura, Taizo, et al.
Publicado: (2014)

Effects of Tenascin C on the Integrity of Extracellular Matrix and Skin Aging
por: Choi, Young Eun, et al.
Publicado: (2020)

Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial–mesenchymal transition-like change of breast cancer cells
por: Katoh, D, et al.
Publicado: (2013)

Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression
por: Fujita, Motomichi, et al.
Publicado: (2021)

Tenascin C in radiation‐induced lung damage: Pathological expression and serum level elevation
por: Toyomasu, Yutaka, et al.
Publicado: (2022)

Expression and degeneration of tenascin-C in human lung cancers.
por: Kusagawa, H., et al.
Publicado: (1998)

Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study
por: Yoshikane, Yukako, et al.
Publicado: (2021)

Advances on the roles of tenascin-C in cancer
por: Yilmaz, Alev, et al.
Publicado: (2022)

Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide
por: Fujita, Motomichi, et al.
Publicado: (2020)

Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis
por: Akatsuka, Tatsuya, et al.
Publicado: (2021)

Advances in tenascin-C biology
por: Midwood, Kim S., et al.
Publicado: (2011)

Tenascin-C: Form versus function
por: Giblin, Sean P, et al.
Publicado: (2014)

Tenascin-C: Exploitation and collateral damage in cancer management
por: Spenlé, Caroline, et al.
Publicado: (2015)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
por: Maruyama, Kazuaki, et al.
Publicado: (2022)

Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation
por: Iyoda, Takuya, et al.
Publicado: (2012)

Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway
por: Paron, Igor, et al.
Publicado: (2011)

Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells
por: Naik, Adviti, et al.
Publicado: (2018)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

Tenascin C in Lung Diseases
por: Donovan, Chantal, et al.
Publicado: (2023)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy
por: Kubo, Yuki, et al.
Publicado: (2020)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro
por: Koch, Felix P, et al.
Publicado: (2011)

Tenascin C in metastasis: A view from the invasive front
por: Lowy, Camille M, et al.
Publicado: (2015)

Transcriptional regulation of tenascin genes
por: Chiovaro, Francesca, et al.
Publicado: (2015)

Tenascin-C Suppresses Rho Activation
por: Wenk, Melissa B., et al.
Publicado: (2000)

Serendipity; Close Encounter of Tenascin C
por: Sakakura, Teruyo
Publicado: (2021)

Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E
por: Yasuda, Mina, et al.
Publicado: (2018)

Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy
por: Kobayashi, Yoshiyuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8acd6eq537ssnt4rb87u0sk51a